Eagle uses ScanRDI®, a unique technology that enables us to deliver sterility testing results in as little as one business day, allowing sterile compounding facilities to release product faster than when utilizing the compendial USP <71> method.
ScanRDI® is an accepted alternative to the official compendial sterility test. Additionally, ScanRDI® fulfills the method suitability requirement as outlined in USP <1223>.
ScanRDI® rapidly detects viable microbial cells without the need for growth or cell multiplication. This forgoes the extended incubation period included in the USP <71> test method.